A 10-year-old with constitutional mismatch repair deficiency-associated colorectal adenocarcinoma received neoadjuvant ipilimumab and nivolumab, achieving partial response. (Journal of Pediatric Hematology/Oncology)
Immunotherapy Shows Response in Pediatric CMMRD-Associated CRC
The CRC Digest